We have determined by deep sequencing the genome wide distribution of MBD2-pulldown DNA from one normal melanocyte cell line and four melanoma cell lines, and by targeted bisulfite sequencing have demonstrated that the CpG islands in the MBD2-affinity captured DNA are enriched for methylated CpG residues. Here, MBD2 is linked to melanoma.